Recent Trials Guiding mRCC Treatment

Panelists discuss how recent clinical trials have shaped treatment algorithms for metastatic renal cell carcinoma (mRCC) by establishing the superiority of immunotherapy–tyrosine kinase inhibitor combinations over single-agent therapies across various risk groups.

EP: 1.KEYNOTE-564: Updates in RCC Treatment and Diagnostic Imaging Pearls

EP: 2.Localized Renal Cell Carcinoma: Current Treatment Considerations

EP: 3.IO-TKI Treatment Regimens in the Treatment of mRCC

Now Viewing

EP: 4.Recent Trials Guiding mRCC Treatment

EP: 5.Sequencing Therapies for Patients With Renal Cell Carcinoma

EP: 6.Final Insights in Care for Patients With Renal Cell Carcinoma

Recent Videos